A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.


Updates from The Motley Fool

Latest updates on Sequenom from Fool.com.  The Fool has written over 200 articles on Sequenom.
Why Sequenom Tumbled Today

Analysts and investors are unimpressed with the company's plans for a turnaround.

Why Sequenom Inc. Shares Plunged

An unexpected court ruling crushes Sequenom. Is this bad news or the buying opportunity investors...



Stock Performance

View Interactive SQNM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sequenom.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): ($0.35)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dirk van den Boom, CEO

100% Approve

Based on 4 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sequenom.

A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers